New answer by Radiation Oncologist at Varian Medical Systems/Allegheny health network (June 12, 2017)
The interim analysis of the GROINSS-V II trial showed a recurrence in 12.2% (10/82) of patients treated with radiation in the setting of positive sentinel lymph node biopsy fo...